Andrea Ellis is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 18,589 shares of BBIO, which is worth approximately $848,773. The most recent transaction as insider was on Jun 20, 2025, when has been sold 6,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K
54.91% 3M change
54.91% 12M change
Total Value Held $848,773

Andrea Ellis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 26.17%
18,589 Common Stock
Apr 14 2025
SELL
Open market or private sale
$350,000 $35.0 p/Share
10,000 Reduced 45.45%
12,000 Common Stock
Apr 14 2025
BUY
Exercise of conversion of derivative security
$84,500 $8.45 p/Share
10,000 Added 31.25%
22,000 Common Stock
Apr 01 2025
SELL
Open market or private sale
$1,021,499 $34.05 p/Share
30,000 Reduced 71.43%
12,000 Common Stock
Apr 01 2025
BUY
Exercise of conversion of derivative security
$253,499 $8.45 p/Share
30,000 Added 41.67%
42,000 Common Stock
Mar 15 2022
BUY
Open market or private purchase
$100,680 $8.39 p/Share
12,000 Added 50.0%
12,000 Common Stock
AE

Andrea Ellis

Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO